Victory Capital Management Inc Instil Bio, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$4.65 - $7.37 $5,993 - $9,499	-1,289 Reduced 6.25%	19,348 $94,000
Q2 2022 Aug 01, 2022	SELL	$4.21 - $11.15 $134 - $356	-32 Reduced 0.15%	20,637 $95,000
Q1 2022 May 04, 2022	SELL	$8.48 - $18.1 $3,612 - $7,710	-426 Reduced 2.02%	20,669 $146,000
Q4 2021 Feb 07, 2022	SELL	$15.37 - $22.5 $17,122 - $25,065	-1,114 Reduced 5.02%	21,095 $361,000
Q3 2021 Nov 02, 2021	BUY	$15.05 - $23.28 $79,479 - $122,941	5,281 Added 31.2%	22,209 $397,000
Q2 2021 Aug 03, 2021	BUY	$15.31 - $24.63 $29,517 - $47,486	1,928 Added 12.85%	16,928 $327,000
Q1 2021 May 04, 2021	BUY	$24.23 - $27.06 $363,450 - $405,900	15,000 New	15,000 $376,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.